Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07536594Not yet recruiting
Randomised trial of Lidocaine Hydrochloride Injection, without epinephrine in Renal colic (2 arms), sponsored by Loma Linda University. Primary endpoint: Response to treatment (>= 50% reduction in pain score) at 30 months. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07536594.